On this episode of Let’s be Blunt, Montel talks with Hemp-OG Chris Boucher about the potential pitfalls of Delta-8 products on the industry. Chris has been involved in the hemp industry since the early 1990’s globally. In 1994, he became the first person in modern times permitted to legally grow a hemp crop in the US, at the USDA Research Center in Brawley, California. In 2014, he established a large, sustainable hemp farm in California to support his educational, commercial, and advocacy activities and now today, he is CEO of Farmtiva, Inc. which breeds and sells CBD fiber and grain seeds and co-founder of Juicetiva Hemp CBDA Powder.

In recent years, the oversupply of CBD extracted from US grown-hemp caused the price of CBD to plummet, and some CBD producers began to experiment. The result was the emergence of Delta-8 products being widely marketed and sold across the country with no regulatory oversight and limited laboratory testing. Most products sold as delta-8-THC typically contain a high percentage of delta-8-THC and small amounts of other cannabinoids, including delta-9-THC, and reaction by-products. Some of the cannabinoids are not naturally found in cannabis. In most cases, nothing is known about the health effects of these impurities.